A2 BIO - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
97980850
Word Mark
A2 BIO
Status
748 - Statement Of Use - To Examiner
Status Date
2025-11-10
Filing Date
2021-10-14
Mark Drawing
3 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Design Searches
260902, 260913, 260921 - Plain single line squares. Two squares. Squares that are completely or partially shaded.
Published for Opposition Date
2023-04-04
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
WOO,SAMUEL M
Statements
Description of Mark
The mark consists of a black square with white frame and black border containing "A2" in white text in the lower right quadrant, with the word BIO in black text appearing under the number 2 and breaking the black and white border.
Disclaimer
"BIO"
Goods and Services
Therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer; biotherapeutics for the treatment and prevention of cancer; medicines for the treatment and prevention of cancer; pharmaceutical products for the treatment and prevention of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer; therapeutics and cell therapies in the nature of cells, proteins and protein complexes for the treatment of cancer; engineered cell therapies in the nature of cells, proteins and protein complexes for medical purposes, namely, the treatment and prevention of cancer; engineered cell therapy platforms consisting of modified cells, cell receptors, proteins and protein complexes; cell platforms consisting of modified cells, cell receptors, proteins and protein complexes for the treatment and prevention of cancer; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer; gene therapy products, namely, genetically engineered tissues for transplant purposes;
Goods and Services
Custom manufacturing of therapeutics, biotherapeutics, medicines, and pharmaceuticals; manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer; biomanufacturing for others, namely, manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer using biological cells in the manufacturing process; cell therapy manufacturing for others; autologous and allogeneic cell manufacturing for others; manufacturing services for others in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing and engineering of biological cells, cellular targets, proteins, and antibodies for others for treatment and prevention of cancer;
Goods and Services
Medical research services; pharmaceutical and biopharmaceutical research and development services; provision of medical and scientific research information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals; identification and development of therapeutic targets for others for the treatment and prevention of cancer; development of therapeutics and cell therapies for treatment and prevention of cancer; research and development of therapeutics and cell therapies targeting targets lost for the treatment and prevention of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; scientific research and development services; providing scientific information relating to treatment and prevention of cancer; research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; medical laboratory services, namely, tissue material processing and analysis in the field of autologous and allogeneic biologic preparations for medical use; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services;
Pseudo Mark
A TWO BIO
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-11-03
Primary Code
005
First Use Anywhere Date
2023-05-01
First Use In Commerce Date
2023-05-01
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2021-11-03
Primary Code
040
First Use Anywhere Date
2023-05-01
First Use In Commerce Date
2023-05-01
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-11-03
Primary Code
042
First Use Anywhere Date
2023-05-01
First Use In Commerce Date
2023-05-01
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Joi A. White CARR & FERRELL LLP
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
289
Reference Number
A0121518
Original Filing Date USPTO
2022-04-06
International Registration Number
1687385
International Registration Date
2022-04-06
International Status Code
480
International Renewal Date
2032-04-06
| Madrid History Events | ||
| Date | Code | Description |
| 2022-04-06 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2022-04-07 | MCERT | MANUALLY CERTIFIED |
| 2022-04-07 | APPST | IR CERTIFIED AND SENT TO IB |
| 2022-06-23 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2022-08-17 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2022-08-22 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2022-08-22 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2022-10-06 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2025-11-11 | DBCRP | DIVISIONAL OF BASE APP NOTICE CREATED, TO BE SENT TO IB |
Trademark Events
| Event Date | Event Description |
| 2021-10-18 | NEW APPLICATION ENTERED |
| 2021-11-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2021-11-04 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2022-07-13 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2022-07-13 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2022-07-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2022-07-20 | ASSIGNED TO EXAMINER |
| 2022-07-22 | NON-FINAL ACTION WRITTEN |
| 2022-07-22 | NON-FINAL ACTION E-MAILED |
| 2022-07-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2023-01-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2023-01-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2023-01-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2023-02-25 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2023-03-15 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2023-04-04 | PUBLISHED FOR OPPOSITION |
| 2023-04-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2023-05-30 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2023-11-17 | SOU TEAS EXTENSION RECEIVED |
| 2023-11-17 | SOU EXTENSION 1 FILED |
| 2023-11-17 | SOU EXTENSION 1 GRANTED |
| 2023-11-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2024-05-14 | SOU TEAS EXTENSION RECEIVED |
| 2024-05-14 | SOU EXTENSION 2 FILED |
| 2024-05-14 | SOU EXTENSION 2 GRANTED |
| 2024-05-15 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2024-11-07 | SOU TEAS EXTENSION RECEIVED |
| 2024-11-07 | SOU EXTENSION 3 FILED |
| 2024-11-07 | SOU EXTENSION 3 GRANTED |
| 2024-11-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2025-05-19 | SOU TEAS EXTENSION RECEIVED |
| 2025-05-19 | SOU EXTENSION 4 FILED |
| 2025-05-20 | SOU EXTENSION 4 GRANTED |
| 2025-05-20 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2025-05-30 | TEAS STATEMENT OF USE RECEIVED |
| 2025-11-07 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2025-05-30 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2025-05-30 | DIVISIONAL REQUEST RECEIVED |
| 2025-11-10 | DIVISIONAL PROCESSING COMPLETE |
| 2025-05-29 | SOU EXTENSION 5 FILED |
| 2025-11-10 | SOU EXTENSION 5 GRANTED |
| 2025-05-30 | USE AMENDMENT FILED |
| 2025-11-10 | STATEMENT OF USE PROCESSING COMPLETE |
| 2025-11-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
